These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35713929)

  • 41. G82S polymorphism of receptor for advanced glycation end products gene and serum soluble RAGE levels in mild cognitive impairment and dementia of Alzheimer's type patients in Turkish population.
    Ataç ZS; Alaylıoğlu M; Dursun E; Gezen-Ak D; Yılmazer S; Gürvit H
    J Clin Neurosci; 2019 Jan; 59():197-201. PubMed ID: 30389362
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between serum levels of the soluble receptor (sRAGE) for advanced glycation endproducts (AGEs) and their receptor (RAGE) in peripheral blood mononuclear cells of children with type 1 diabetes mellitus.
    Dettoraki A; Gil AP; Spiliotis BE
    J Pediatr Endocrinol Metab; 2009 Oct; 22(10):895-904. PubMed ID: 20020577
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Not Available].
    Kumar V; Sulaj A; Fleming T; Nawroth PP
    Exp Clin Endocrinol Diabetes; 2018 Mar; 126(3):141-147. PubMed ID: 28926869
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ADAM10 modulates calcitriol-regulated RAGE in cardiomyocytes.
    Lee TW; Kao YH; Lee TI; Chen YJ
    Eur J Clin Invest; 2017 Sep; 47(9):675-683. PubMed ID: 28722189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodes.
    Kerkvliet NI; Steppan LB; Vorachek W; Oda S; Farrer D; Wong CP; Pham D; Mourich DV
    Immunotherapy; 2009 Jul; 1(4):539-47. PubMed ID: 20174617
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between Advanced Glycation End Products, Soluble RAGE Receptor, and Endothelium Dysfunction, Evaluated by Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with Mild and Resistant Hypertension.
    Gryszczyńska B; Budzyń M; Begier-Krasińska B; Osińska A; Boruczkowski M; Kaczmarek M; Bukowska A; Iskra M; Kasprzak MP
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412635
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolic Derangements Contribute to Reduced sRAGE Isoforms in Subjects with Alzheimer's Disease.
    Fuller KNZ; Miranda ER; Thyfault JP; Morris JK; Haus JM
    Mediators Inflamm; 2018; 2018():2061376. PubMed ID: 29681765
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The AGE-RAGE Axis and RAGE Genetics in Chronic Obstructive Pulmonary Disease.
    Sharma A; Kaur S; Sarkar M; Sarin BC; Changotra H
    Clin Rev Allergy Immunol; 2021 Apr; 60(2):244-258. PubMed ID: 33170477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes.
    Yamagishi S; Matsui T; Nakamura K
    Curr Drug Targets; 2007 Oct; 8(10):1138-43. PubMed ID: 17979674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Soluble Receptor for Advanced Glycation End Products (sRAGE) is Up-Regulated in Multiple Sclerosis Patients Treated with Interferon β-1a.
    Rahimi M; Aghabozorg Afjeh SS; Omrani MD; Arsang-Jang S; Ganji M; Noroozi R; Taheri M; Ghafouri-Fard S
    Cell Physiol Biochem; 2018; 46(2):561-567. PubMed ID: 29617694
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and without Type 2 Diabetes.
    Fotheringham AK; Bagger JI; Borg DJ; McCarthy DA; Holst JJ; Vilsbøll T; Knop FK; Forbes JM
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 32987824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. sRAGE prolonged stem cell survival and suppressed RAGE-related inflammatory cell and T lymphocyte accumulations in an Alzheimer's disease model.
    Oh S; Son M; Choi J; Lee S; Byun K
    Biochem Biophys Res Commun; 2018 Jan; 495(1):807-813. PubMed ID: 29127006
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Soluble form of a receptor for advanced glycation end products (sRAGE) as a biomarker.
    Yamagishi S; Matsui T
    Front Biosci (Elite Ed); 2010 Jun; 2(4):1184-95. PubMed ID: 20515790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic engineering of regulatory T cells for treatment of autoimmune disorders including type 1 diabetes.
    Tuomela K; Levings MK
    Diabetologia; 2024 Apr; 67(4):611-622. PubMed ID: 38236408
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women.
    Pertynska-Marczewska M; Merhi Z
    Reprod Sci; 2015 Jul; 22(7):774-82. PubMed ID: 25228634
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RAGE-mediated T cell metabolic reprogramming shapes T cell inflammatory response after stroke.
    Zhang Y; Li F; Chen C; Li Y; Xie W; Huang D; Zhai X; Yu W; Wan J; Li P
    J Cereb Blood Flow Metab; 2022 Jun; 42(6):952-965. PubMed ID: 34910890
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dietary protein intake and circulating advanced glycation end product/receptor for advanced glycation end product concentrations in the Health, Aging, and Body Composition Study.
    Brinkley TE; Semba RD; Kritchevsky SB; Houston DK;
    Am J Clin Nutr; 2020 Dec; 112(6):1558-1565. PubMed ID: 33301008
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ethyl Pyruvate Stimulates Regulatory T Cells and Ameliorates Type 1 Diabetes Development in Mice.
    Koprivica I; Vujičić M; Gajić D; Saksida T; Stojanović I
    Front Immunol; 2018; 9():3130. PubMed ID: 30687329
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.
    Tan KC; Shiu SW; Chow WS; Leng L; Bucala R; Betteridge DJ
    Diabetologia; 2006 Nov; 49(11):2756-62. PubMed ID: 16969649
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: myth or reality.
    Prasad K
    Int J Angiol; 2014 Mar; 23(1):11-6. PubMed ID: 24627612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.